ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denning, D. W.
Right arrow Articles by Niven, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denning, D. W.
Right arrow Articles by Niven, R. M.
Eur Respir J 2006; 27:615-626
Copyright ©ERS Journals Ltd 2006

The link between fungi and severe asthma: a summary of the evidence

D. W. Denning1,2, B. R. O'Driscoll3, C. M. Hogaboam4, P. Bowyer1,2 and R. M. Niven1,2

1 School of Medicine, Manchester University, 2 Dept of Cardiothoracic Medicine, Wythenshawe Hospital, and 3 Hope Hospital, Manchester, UK, 4 Dept of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.

CORRESPONDENCE: D. W. Denning, Education and Research Centre, Wythenshawe Hospital, Southmoor Rd, Manchester M23 9LT, UK. Fax: 44 1612915806. E-mail: ddenning{at}manchester.ac.uk

Keywords: Aspergillosis, asthma clinical/basic investigations, asthma epidemiology, asthma immunology, fungi

Received: June 27, 2005
Accepted November 12, 2005

There is current evidence to demonstrate a close association between fungal sensitisation and asthma severity. Whether such an association is causal remains to be confirmed, but this is explored by means of a detailed literature review. There is evidence from two randomised controlled trials that, in the example of allergic bronchopulmonary aspergillosis (ABPA), treatment with systemic antifungal therapy can offer a therapeutic benefit to ~60% of patients. ABPA is only diagnosed if a combination of clinical and immunological criteria is achieved. It is not known whether such cases are a discrete clinical entity or part of a spectrum of the pulmonary allergic response to fungi or fungal products.

This paper describes the epidemiological evidence that associates severity of asthma with fungi and discusses possible pathogenetic mechanisms. Many airborne fungi are involved, including species of Alternaria, Aspergillus, Cladosporium and Penicillium, and exposure may be indoors, outdoors or both. The potential for a therapeutic role of antifungal agents for patients with severe asthma and fungal sensitisation is also explored.

Not only are many patients with severe asthma desperately disabled by their disease, but, in the UK alone, asthma accounts for 1,500 deaths per yr. The healthcare costs of these patients are enormous and any treatment option merits close scrutiny. Within this report, the case for the consideration of a new term related to this association is put forward. The current authors propose the term "severe asthma with fungal sensitisation". However, it is recognised that enhanced and precise definition of fungal sensitisation will require improvements in diagnostic testing.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Yoon, J. U. Ponikau, C. B. Lawrence, and H. Kita
Innate Antifungal Immunity of Human Eosinophils Mediated by a {beta}2 Integrin, CD11b
J. Immunol., August 15, 2008; 181(4): 2907 - 2915.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A. Woodcock
Moulds and asthma: time for indoor climate change?
Thorax, September 1, 2007; 62(9): 745 - 746.
[Full Text] [PDF]


Home page
ThoraxHome page
M L Burr, I P Matthews, R A Arthur, H L Watson, C J Gregory, F D J Dunstan, and S R Palmer
Effects on patients with asthma of eradicating visible indoor mould: a randomised controlled trial
Thorax, September 1, 2007; 62(9): 767 - 772.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
E. Levdansky, J. Romano, Y. Shadkchan, H. Sharon, K. J. Verstrepen, G. R. Fink, and N. Osherov
Coding Tandem Repeats Generate Diversity in Aspergillus fumigatus Genes
Eukaryot. Cell, August 1, 2007; 6(8): 1380 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. D. Fixman, A. Stewart, and J. G. Martin
Basic mechanisms of development of airway structural changes in asthma
Eur. Respir. J., February 1, 2007; 29(2): 379 - 389.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
G. Hageskal, A. K. Knutsen, P. Gaustad, G. S. de Hoog, and I. Skaar
Diversity and Significance of Mold Species in Norwegian Drinking Water
Appl. Envir. Microbiol., December 1, 2006; 72(12): 7586 - 7593.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
R W Atkinson, D P Strachan, H R Anderson, S Hajat, and J Emberlin
Temporal associations between daily counts of fungal spores and asthma exacerbations
Occup. Environ. Med., September 1, 2006; 63(9): 580 - 590.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.